Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1997 2
1999 4
2000 1
2001 3
2002 2
2003 2
2004 5
2005 3
2006 3
2007 5
2008 4
2009 3
2010 8
2011 9
2012 8
2013 9
2014 3
2015 5
2016 2
2017 11
2018 10
2019 9
2020 7
2021 6
Text availability
Article attribute
Article type
Publication date

Similar articles for PMID: 29947477

110 results
Results by year
Filters applied: . Clear all
Page 1
Lack of Impact by SCY-078, a First-in-Class Oral Fungicidal Glucan Synthase Inhibitor, on the Pharmacokinetics of Rosiglitazone, a Substrate for CYP450 2C8, Supports the Low Risk for Clinically Relevant Metabolic Drug-Drug Interactions.
Wring S, Murphy G, Atiee G, Corr C, Hyman M, Willett M, Angulo D. Wring S, et al. J Clin Pharmacol. 2018 Oct;58(10):1305-1313. doi: 10.1002/jcph.1146. Epub 2018 May 10. J Clin Pharmacol. 2018. PMID: 29746713 Free PMC article. Clinical Trial.
SCY-078 Is Fungicidal against Candida Species in Time-Kill Studies.
Scorneaux B, Angulo D, Borroto-Esoda K, Ghannoum M, Peel M, Wring S. Scorneaux B, et al. Antimicrob Agents Chemother. 2017 Feb 23;61(3):e01961-16. doi: 10.1128/AAC.01961-16. Print 2017 Mar. Antimicrob Agents Chemother. 2017. PMID: 28069658 Free PMC article.
Preclinical Pharmacokinetics and Pharmacodynamic Target of SCY-078, a First-in-Class Orally Active Antifungal Glucan Synthesis Inhibitor, in Murine Models of Disseminated Candidiasis.
Wring SA, Randolph R, Park S, Abruzzo G, Chen Q, Flattery A, Garrett G, Peel M, Outcalt R, Powell K, Trucksis M, Angulo D, Borroto-Esoda K. Wring SA, et al. Antimicrob Agents Chemother. 2017 Mar 24;61(4):e02068-16. doi: 10.1128/AAC.02068-16. Print 2017 Apr. Antimicrob Agents Chemother. 2017. PMID: 28137806 Free PMC article.
110 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page